Cargando…
Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
Multiple sclerosis is a chronic neuroinflammatory disease with a highly heterogeneous disease course. Preventing lasting disability requires early identification of persons at risk and novel approaches towards patient stratification for personalized treatment decisions. In this comment, we discuss t...
Autores principales: | Engel, Sinah, Zipp, Frauke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020060/ https://www.ncbi.nlm.nih.gov/pubmed/35440092 http://dx.doi.org/10.1186/s13073-022-01044-8 |
Ejemplares similares
-
Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
por: Steffen, Falk, et al.
Publicado: (2022) -
Implications of extreme serum neurofilament light chain levels for
the management of patients with relapsing multiple sclerosis
por: Engel, Sinah, et al.
Publicado: (2021) -
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression
por: Uphaus, Timo, et al.
Publicado: (2021) -
Supplementary medication in multiple sclerosis: Real-world experience
and potential interference with neurofilament light chain
measurement
por: Pape, Katrin, et al.
Publicado: (2020) -
A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric
Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk
Factors
por: Engel, Sinah, et al.
Publicado: (2021)